News

Insurers are cutting coverage, citing costs. But there’s seldom any discussion of the return on investment from these drugs ...
Senior Advocate Diya Kapur, representing the petitioner, informed the court that some gyms were promoting these drugs as a ...
The Delhi High Court on Tuesday disposed of a public interest litigation (PIL) raising alarm over the off-label and ...
Jamun seed powder, derived from the Indian blackberry, has been used in Ayurvedic medicine for blood sugar control. Rich in jamboline and jambosine, i ...
High emotional demands and confrontations in person-contact jobs raise the risk for type 2 diabetes, with the risk growing ...
Despite incomplete evidence, longevity enthusiasts are experimenting with SGLT2 inhibitors in their quest to live healthier ...
This discovery could make treatment for an eye disease affecting millions with diabetes more accessible and affordable.
Tegoprubart to be Used as Immunosuppressive Agent in Cohort C of Sernova’s Phase 1/2 Cell Pouch Bio-hybrid Organ Clinical Trial in Patients with Type 1 Diabetes ...
These Diabetes Drugs Are Finding New Life as an Antiaging Hack Despite incomplete evidence, longevity enthusiasts are experimenting with SGLT2 inhibitors in their quest to live healthier for longer By ...
The widely used class of drugs, called SGLT2 inhibitors and sold under brand names such as Jardiance and Farxiga, have been on the market for over a decade as Type 2 diabetes medications.
Ozempic, or semaglutide, is an anti-diabetic medication primarily used to treat type 2 diabetes. However, people have recognised its effectiveness in reducing weight, especially in obese people.
Researchers at the Case Western Reserve School of Medicine have found that semaglutide, a popular diabetes and weight-loss ...